JB/CALL/PFIZER INC/28/0.1/20.12.24 | Market Closed - Swiss Exchange 16:20:00 07/06/2024 BST | ||
| 0.27 CHF | -6.90% |
|
| Current month | +12.50% | ||
| 1 month | +22.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 0.27 | -6.90% |
| 03/06/24 | 0.29 | +20.83% |
| 31/05/24 | 0.24 | +9.09% |
Delayed Quote Swiss Exchange
Last update June 07, 2024 at 04:20 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | Bank Julius Bär |
| PFYZJB | |
| ISIN | CH1308924831 |
| Date issued | 14/12/2023 |
| Strike | 28 $ |
| Maturity | 20/12/2024 (194 Days) |
| Parity | 10 : 1 |
| Emission price | 0.24 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.37 CHF |
|---|---|
| Lowest since issue | 0.13 CHF |
| Spread | 0.01 CHF |
| Spread % | 3.70% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.58
USD
Average target price
31.92
USD
Spread / Average Target
+11.67%
- Stock Market
- Warrants
- PFYZJB Warrant
